Total, Bioavailable, and Free Vitamin D Levels and Their Prognostic Value in Pulmonary Arterial Hypertension

Impacto

Downloads

Downloads per month over past year

Callejo Arranz, María and Mondejar Parreño, Gema and Esquivel Ruiz, Sergio Antonio and Olivencia Plaza, Miguel Ángel and Moreno Gutiérrez, Laura and Blanco, Isabel and Escribano Subías, María Pilar and Cogolludo Torralba, Ángel Luis and Barbera, Joan Albert and Pérez Vizcaíno, Francisco (2020) Total, Bioavailable, and Free Vitamin D Levels and Their Prognostic Value in Pulmonary Arterial Hypertension. Journal of Clinical Medicine, 9 (2). p. 448. ISSN 2077-0383

[thumbnail of jcm-09-00448-v2.pdf]
Preview
PDF
Creative Commons Attribution.

2MB

Official URL: https://doi.org/10.3390/jcm9020448




Abstract

Introduction: Epidemiological studies suggest a relationship between vitamin D deficiency and cardiovascular and respiratory diseases. However, whether total, bioavailable, and/or free vitamin D levels have a prognostic role in pulmonary arterial hypertension (PAH) is unknown. We aimed to determine total, bioavailable, and free 25-hydroxy-vitamin D (25(OH)vitD) plasma levels and their prognostic value in PAH patients. Methods: In total, 67 samples of plasma from Spanish patients with idiopathic, heritable, or drug-induced PAH were obtained from the Spanish PH Biobank and compared to a cohort of 100 healthy subjects. Clinical parameters were obtained from the Spanish Registry of PAH (REHAP). Results: Seventy percent of PAH patients had severe vitamin D deficiency (total 25(OH)vitD < 10 ng/mL) and secondary hyperparathyroidism. PAH patients with total 25(OH)vitD plasma above the median of this cohort (7.17 ng/mL) had better functional class and higher 6-min walking distance and TAPSE (tricuspid annular plane systolic excursion). The main outcome measure of survival was significantly increased in these patients (age-adjusted hazard ratio: 5.40 (95% confidence interval: 2.88 to 10.12)). Vitamin D-binding protein (DBP) and albumin plasma levels were downregulated in PAH. Bioavailable 25(OH)vitD was decreased in PAH patients compared to the control cohort. Lower levels of bioavailable 25(OH)vitD (<0.91 ng/mL) were associated with more advanced functional class, lower exercise capacity, and higher risk of mortality. Free 25(OH)vitD did not change in PAH; however, lower free 25(OH)vitD (<1.53 pg/mL) values were also associated with high risk of mortality. Conclusions: Vitamin D deficiency is highly prevalent in PAH, and low levels of total 25(OH)vitD were associated with poor prognosis.


Item Type:Article
Uncontrolled Keywords:pulmonary arterial hypertension; vitamin D; survival; prognosis
Subjects:Medical sciences > Medicine > Pharmacology
ID Code:65891
Deposited On:07 Jun 2021 14:43
Last Modified:08 Jun 2021 18:34

Origin of downloads

Repository Staff Only: item control page